Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, April 3, 2023
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
Francois Brisebois Reiterated (AVDL) at Buy and Held Target at $20 on, Apr 3rd, 2023
Francois Brisebois of Oppenheimer, Reiterated "Avadel Pharmaceuticals plc" (AVDL) at Buy and Held Target at $20 on, Apr 3rd, 2023.
Francois has made no other calls on AVDL in the last 4 months.
There is 1 other peer that has a rating on AVDL. Out of the 1 peers that are also analyzing AVDL, 0 agree with Francois's Rating of Hold.
This is the rating of the analyst that currently disagrees with Francois
- Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $14 on, Thursday, March 23rd, 2023
